Delivery Order SPE2DB20D1100-SPE2DB26FE0TA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams, with a ceiling value of $1,235.12. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a $3,599.50 delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $1,185.93 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 18, 2025, and will be fulfilled from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a $1,376.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit dose 5 gram packets. This non-set-aside competitive award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,036.80 to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by October 16, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packets under a firm fixed-price contract with an ultimate completion date of September 12, 2025. This non-set-aside award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Testosterone 1.62% (1.25 G) packets with a ceiling value of $1,422.94. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate completion date for this order is...
- The Defense Logistics Agency awarded a $2,169.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a completion deadline of September 29, 2025. This non-set-aside contract was competitively awarded on September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,646.92 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB26FE0TADelivery Order
The Defense Logistics Agency awarded a $1,528.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. The contract, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-set-aside competitive award. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this testosterone supply requirement as part of its broader role in supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order supports DLA's medical supply chain operations and aligns with the agency's commitment to ensuring adequate pharmaceutical inventory for defense healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/17/25 |